Glenmark Pharmaceuticals, USA, has been granted final approval by the United States Food and Drug Administration (USFDA) for Acyclovir Oint...

Ancobon capsules had sales of $46.6 million in the US, said Lupin, citing IMS Moving Annual Turnover (MAT) data for March 2017.

Skincare is the largest category in the cosmetics industry, accounting for more than one-third of the global market, according to data trac...

The chairman of Piramal Group & Shriram Group believes companies need to make conscientious decisions to gain their consumers and stakehold...

According to data from Bloomberg, branded drugs with more than $14 billion in annual sales will lose patent protection in 2017.

The company's tablets are generic versions of Valeant's Wellbutrin XL tablets in the same strengths, Cipla said.

The drugmaker said in a statement on Wednesday that it’s cooperating with the probe, which is being led by the US Attorney’s Office for the...

Stocks rallied to new highs after the afternoon release of the Federal Reserve's March meeting minutes in Washington.

Valeant Pharmaceuticals International Inc said on Monday that Chief Executive Michael Pearson will step down and that the company appointed...

Aurobindo Pharma has received final approval from the US health regulator to manufacture and market Famotidine Tablets used for acid reflux...

Saunders, 45, an intrepid deal maker, has a history of eventually leading companies that he had helped combine.

Valeant plunged as much as 40%, prompting a public response from the company and creating billions of dollars of losses for its hedge fund ...

Piramal Enterprises today said it has acquired over-the-counter skincare brand Caladryl in India from Valeant Pharmaceuticals International...

In 2008, it bought the Asia-Pacific operations of California-based Valeant Pharmaceuticals. In 2010, it acquired 70% in Indonesian drugs ma...

Diltiazem HCl extended-release capsules are indicated for the treatment of hypertension and for the management of angina.

Teva Pharmaceutical Industries Ltd agreed to buy 57% of Taiyo Pharmaceutical Industry Co Ltd. for $460 million and bid for the rest.

Mumbai-based Sun Pharma is about to give its bulk drug business a shot in the arm - it’s scouting for tie-ups in Europe to supply a range o...